Influence of certain factors on the manifestations of the adverse effects of metrizamide myelography.
Although metrizamide is now being superseded by other contrast media, the mechanisms of its side effects may be of fundamental importance. One hundred and four consecutive patients with suspected cervical cord or root lesion were studied prospectively for factors which might influence the side effects of metrizamide myelography. Elderly patients were more prone to develop mental confusion. An earlier onset of dizziness and/or vertigo was associated with the lumbar route of intrathecal injection. Perhaps surprisingly, phenobarbitone prophylaxis shortened the duration of confusion and delayed the onset of headaches. Other factors, viz. sex, excess intracranial flow of metrizamide and myelographic blockage were not shown to have a significant influence on the adverse reactions.
D000328:Adult; D000368:Aged; D000375:Aging; D003221:Confusion / Q000139:chemically induced / Q000188:drug therapy; D004244:Dizziness / Q000139:chemically induced; D006261:Headache / Q000139:chemically induced / Q000188:drug therapy / Q000503:physiopathology; D006801:Humans; D008793:Metrizamide / Q000009:adverse effects*; D008875:Middle Aged; D009192:Myelography; D009325:Nausea / Q000139:chemically induced; D010634:Phenobarbital / Q000627:therapeutic use
D008793:Metrizamide; D010634:Phenobarbital